Asian shares are mostly declining amid uncertainty ahead of the U.S. election next Tuesday. Benchmarks fell in early Thursday ...

Eli Lilly (LLY) expects to start selling its weight-loss drug tirzepatide, branded as Mounjaro, in Hong Kong as early as the end of this year ...

Eli Lilly & Co. (NYSE:LLY) plans to start selling its popular weight-loss medication, Mounjaro, in Hong Kong by the end of ...

Learn how to grow your wealth through smart investing strategies and financial planning in this informative article by a ...

Eli Lilly to Introduce Mounjaro Weight-Loss Drug in Hong Kong by Year-End Global pharmaceutical giant Eli Lilly is gearing up ...

Eli Lilly expects to start selling its weight-loss drug in Hong Kong as early as the end of this year, Bloomberg News ...

Credit: Jenna Philpott/GlobalData. An Eli Lilly executive has said the company will “build a new way of doing science” as part of its £279m ($363m) pledge to boost the UK’s life science sector. A ...

U.S. pharmaceutical giant Eli Lilly is exploring whether obesity drugs could be used to curb joblessness after signing a major investment deal with the U.K. The U.S. pharmaceutical company and ...

Last week, the Food and Drug Administration declared an end to the shortage of Eli Lilly’s tirzepatide, sold under the brand name Mounjaro for diabetes and Zepbound for obesity. The move was a ...

The high court heard arguments Thursday morning on Attorney General Dana Nessel’s effort to investigate and potentially sue the drug company Eli Lilly on the grounds that its insulin pricing ...

2024 /PRNewswire/ -- KeyBioscience and Eli Lilly and Company have agreed to extend their collaboration on the development of Dual Amylin Calcitonin Receptor Agonists (DACRA), a new class of ...